• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Latest News about atopic dermatitis

    Recent news which mentions atopic dermatitis

    Johnson & Johnson To Acquire Early-Stage Eczema Treatment Developer Proteologix For $850M
    Tickers JNJ NEWS SWAV
    Tags Market News Health Care Large Cap
    From Benzinga
    Eli Lilly Reveals More Phase 3 Data From Lebrikizumab Trial In Atopic Dermatitis
    Tickers LLY
    Tags atopic dermatitis Benzinga News
    From Benzinga
    VYNE Therapeutics Shares Gain After Positive Atopic Dermatitis Trial Of FMX114
    Tickers VYNE
    Tags General VYNE Market News
    From Benzinga
    Sanofi - Regeneron's Dupixent Under FDA Priority Review For Children Under 5 Years With Atopic Dermatitis
    Tickers REGN SNY
    Tags atopic dermatitis News Benzinga
    From Benzinga
    ASLAN Pharma Kickstarts Mid-Stage Atopic Dermatitis Trial, Data Expected In 2023
    Tickers ASLN
    Tags Phase 2 Trial Biotech Health Care
    From Benzinga
    FDA Approves AbbVie's Upadacitinib For Refractory Atopic Dermatitis In Patients 12 Years & Older
    Tickers ABBV
    Tags ABBV atopic dermatitis Guidance
    From Benzinga
    EXCLUSIVE: Hoth Therapeutics Starts Dosing In Second Cohort Of Atopic Dermatitis Trial With BioLexa
    Tickers HOTH
    Tags atopic dermatitis Biotech Health Care
    From Benzinga
    Connect Biopharma's Mid-Stage Atopic Dermatitis Trial Meets Primary Endpoint
    Tickers CNTB
    Tags Trading Ideas Small Cap General
    From Benzinga
    AbbVie Presents New Upadacitinib Data In Atopic Dermatitis
    Tickers ABBV
    Tags atopic dermatitis Biotech ABBV
    From Benzinga
    Pfizers' JAK Inhibitor Approved In Japan For Atopic Dermatitis
    Tickers PFE
    Tags atopic dermatitis Biotech Health Care
    From Benzinga
    Why Did ASLAN Pharma Shares Plunge Despite Positive Atopic Dermatitis Trial Data?
    Tickers ASLN
    Tags ASLN General Market News
    From Benzinga
    Incyte's Topical JAK Inhibitor Scores FDA Approval For Atopic Dermatitis
    Tickers INCY
    Tags INCY FDA General
    From Benzinga
    Pfizer's Abrocitinib Beats Dupixent Late-stage Eczema Trial
    Tickers PFE REGN SNY
    Tags Biotech Market News Phase 3 Trial
    From Benzinga
    Dupixent Becomes First Biologic To Show Benefit In Infant Patients With Atopic Dermatitis
    Tickers REGN SNY
    Tags Market News Health Care Biotech
    From Benzinga
    Lilly's Lebrikizumab Shows Clinical Benefit In Late-Stage Atopic Eczema Trials
    Tickers LLY
    Tags Market News Health Care Phase 3 Trial
    From Benzinga
    VYNE Therapeutics Stock Drops On Potential Sale Of Topical Minocycline Franchise
    Tickers VYNE
    Tags VYNE General inflammatory diseases
    From Benzinga
    FDA Will Not Meet Goal Dates For Pfizer's Xeljanz, Abrocitinib Applications
    Tickers PFE
    Tags Biotech Health Care Market News
    From Benzinga
    AbbVie, Lilly Atopic Dermatitis Treatments Hit With Further Delays With FDA
    Tickers ABBV INCY LLY
    Tags atopic dermatitis ABBV Benzinga
    From Benzinga
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.